Multivariable logistic regression analysis showed that eGFR, baseline Hb level, duration of 12 weeks of treatment, and decrease in Hb% (weeks 0–2) were significantly associated with the likelihood of developing anemia (p < 0.05) [42]. This evidence concerns the gene GSTM1 and anemia.